Essential elements of personalized medicine

被引:30
作者
Burke, Wylie [1 ]
Trinidad, Susan Brown [1 ]
Press, Nancy A. [2 ,3 ]
机构
[1] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Sch Med, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
Personalized medicine; Genetics; Genomics; Pharmacogenomics; Prostate cancer; Health technology assessment; DISPARITIES; TECHNOLOGY; ABACAVIR; RISK;
D O I
10.1016/j.urolonc.2013.09.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Genomic information has been promoted as the basis for "personalized" health care. We considered the benefits provided by genornic testing in context of the concept of personalized medicine. Materials and Methods: We evaluated current and potential uses of genomic testing in health care, using prostate cancer as an example, and considered their implications for individualizing or otherwise improving health care. Results and Conclusions: Personalized medicine is most accurately seen as a comprehensive effort to tailor health care to the individual, spanning multiple dimensions. While genomic tests will offer many potential opportunities to improve the delivery of care, including the potential for genomic research to offer opportunities to improve prostate cancer screening and treatment, such advances do not in themselves constitute a paradigm shift in the delivery of health care. Rather, personalized medicine is based on a partnership between clinician and patient that utilizes shared decision making to determine the best health care options among the available choices, weighing the patient's personal values and preferences together with clinical findings. This approach is particularly important for difficult clinical decisions involving uncertainty and trade-offs, such as those involved in prostate cancer screening and management. The delivery of personalized medicine also requires adequate health care access and assurance that basic health needs have been met. Substantial research investment will be needed to identify how genomic tests can contribute to this effort. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 19 条
[11]   Eight Americas: Investigating mortality disparities across races, counties, and race-counties in the United States [J].
Murray, Christopher J. L. ;
Kulkarni, Sandeep C. ;
Michaud, Catherine ;
Tomijima, Niels ;
Bulzacchelli, Maria T. ;
Iandiorio, Terrell J. ;
Ezzati, Majid .
PLOS MEDICINE, 2006, 3 (09) :1513-1524
[12]  
Phillips E, 2009, MOL DIAGN THER, V13, P1, DOI 10.2165/01250444-200913010-00001
[13]   The Genetics of Cancer Risk [J].
Pomerantz, Mark M. ;
Freedman, Matthew L. .
CANCER JOURNAL, 2011, 17 (06) :416-422
[14]  
Schoenborn JR, 2013, CLIN CANC RES
[15]   Choose your method: A comparison of phenomenology, discourse analysis, and grounded theory [J].
Starks, Helene ;
Trinidad, Susan Brown .
QUALITATIVE HEALTH RESEARCH, 2007, 17 (10) :1372-1380
[16]   Personalizing medicine: Futures present and past [J].
Tutton, Richard .
SOCIAL SCIENCE & MEDICINE, 2012, 75 (10) :1721-1728
[17]  
United States Preventive Services Task Force, Recommendation: prostate cancer: screening
[18]  
Wilkes M, 2013, J GEN INTERN MED
[19]  
Yurkiewicz S, 2010, HASTINGS CENT REP, V40, P14